Bortezomib, also known by its brand name Velcade, is a medication commonly used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs called proteasome inhibitors, which work by blocking the action of proteasomes, enzymes that break down proteins in cells. By inhibiting proteasomes, bortezomib can help to slow the growth and spread of cancer cells.

This medication is typically administered intravenously and is often used in combination with other chemotherapy drugs to maximize its effectiveness. Bortezomib has been shown to be effective in treating both newly diagnosed and relapsed cases of multiple myeloma, as well as mantle cell lymphoma.

As with any medication, bortezomib can cause side effects. Common side effects may include nausea, diarrhea, fatigue, and low blood cell counts. It is important to discuss any potential side effects with your healthcare provider and report any unusual symptoms promptly.

It is also important to follow your healthcare provider’s instructions carefully when taking bortezomib. This may include following a specific dosing schedule and attending regular monitoring appointments to assess your response to treatment.

Overall, bortezomib is an important medication in the treatment of certain types of cancer and has been shown to be effective in improving outcomes for many patients. If you have been prescribed bortezomib, it is important to work closely with your healthcare team to ensure that you are receiving the best possible care.